PulseCath B.V. develops, manufactures and markets minimal invasive circulatory support systems which are safe, effective, and very cost effective.
Pulsecath’s lead product, the iVAC 2L™, is a percutaneous Ventricular Assist Device (pVAD) that generates approxymately 2.5 L/min of pulsatile flow and can be inserted through the femoral artery.
Portfolio: MedSciences Seed Fund B.V. and MedSciences Capital II B.V.
Current stage: CE mark and market growth.